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The value of amino acids and vegetable oil derivatives as raw materials for the preparation of surfactants was recognized
as soon as they were discovered early in the last century. Amino acid-based surfactants, which have an amino acid
residue as a hydrophilic moiety, are reviewed with respect to their synthesis, properties and some applications. The
review covers three main categories of amino acid-based surfactants: Na-acyl, N-alkyl amide and O-alkyl ester
derivatives among the linear or single chain amino acid-based surfactants; Na,
Nw-bis(Na-acylarginine)a,w-alkylendiamides, which are gemini amino acid-based surfactants; and
1-monoacyl-rac-glycero-3-O-(Na-acetyl-L-amino acid) and 1,2-diacyl-rac-glycero-3-O-(Na-acetyl-L-amino acid), both
amino acid-based surfactants with glycerolipid-like structures.
1 Introduction
Surfactants are one of the most representative chemical products,
which are consumed in large quantities every day on a worldwide
scale. Since it is known that surface-active compounds can
adversely affect the aquatic environment, the biodegradability and
biocompatibility of surfactants have become almost as important as
their functional performance to the consumer. Because of this, there
is a pressing need for development of efficient novel surfactants
that are biodegradable and biocompatible.1
Surfactants of this kind can be obtained by designing molecules
that mimic natural amphiphilic structures, e.g. phospholipids,2 Na-
acyl amino acids3 and alkyl-glucosides.4 Surfactant molecules from
renewable raw materials that mimic natural lipoamino acids are one
of the preferred choices for food, pharmaceutical and cosmetic
applications. Given their natural and simple structure they show
low toxicity and quick biodegradation.5 They can be produced by
biotechnological and chemical methods using renewable raw
materials such as amino acids and vegetable oils.6–12 The value of
amino acids as raw materials for the preparation of surfactants was
recognized as soon as they were discovered early in the last
century.13 Initially they were used as preservatives for medical and
cosmetic applications. Moreover, they were found to be active
against various disease-causing bacteria, tumors, and viruses.14–16
The combination of polar amino acids/peptides (hydrophilic
moiety) and non-polar long chain compounds (hydrophobic
moiety) for building up the amphiphilic structure has produced
molecules with high surface activity. There is a large variety of
amino acid/peptide structures. Moreover, the fatty acid chains can
vary in their structure, length and number. These facts explain their
wide structural diversity and different physicochemical and
biological properties.5,10,17,18
The amino acid or peptide moiety determines the main
differences of adsorption, aggregation and biological activity
between the amino acid/peptide-based surfactants. Hence, cationic,
anionic, non-ionic and amphoteric surfactants can be obtained
depending on the free functional groups. Further modification of
these groups allows a fine-tuning of their properties to meet almost
every particular application.
The amino acids and long aliphatic chains can be combined with
each other to generate three main structures (Scheme 1) of amino
acid-based surfactants namely linear or single chain 1, dimeric or
gemini 2 and glycerolipid-like structures 3. Linear structures 1
Scheme 1 Structures of amino acid-based surfactants: (1) Linear or single
chain, (2) Dimeric or Gemini and (3) Glycerolipid-like structures. The
amino acid constitutes the polar head of the surfactant. The hydrocarbon
alkyl chain constitutes the hydrophobic moiety.
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consist of an amino acid bearing at least one hydrophobic tail.
Gemini or dimeric are amphipathic structures 2 with two polar
heads (i.e. two amino acids) and two hydrophobic tails per
molecule separated by a covalently bonded spacer. Glycerolipid-
like structures 3 can be considered analogues of mono-, diglycer-
ides and phospholipids, and consist of one polar head and one or
two hydrophobic moieties linked together through a glycerol
skeleton.
This review is concerned with the preparation and the structure–
activity relationship studies of amino acid-based surfactants of
single chain, double chain gemini and glycerolipid-like structures
for adsorption, self-assembling, and biological properties.
2 Single chain amino acid/peptide surfactants
2.1 Synthesis
Acidic, basic, or neutral amino acids such as aspartic acid, glutamic
acid, arginina, alanine, glycine, leucine, proline, serine, and protein
hydrolysates have been used as starting materials to synthesize
single chain amino acid surfactants commercially and experimen-
tally.10
Amino acids are linked to long aliphatic chains through the a-
amino, a-COOH or side chain groups (Scheme 2).
Thus, fatty acids or alkyl halides can react with amino groups
yielding the corresponding N-acyl and N-alkyl derivatives (Scheme
2, compounds 1 and 2), respectively. Alternatively, the carboxyl
group of the amino acid can be condensed with alkyl amines or
aliphatic alcohols to give N-alkyl amides and esters (Scheme 2,
compounds 3 and 4, respectively).
Among the different types of linkages between the long aliphatic
chain and the amino acid, the N-acyl (Scheme 3, series 1), N-alkyl
amides (Scheme 3, series 2) and O- alkyl esters (Scheme 3, series
3) of arginine have attracted much interest in our group due to their
low toxicity and high biodegradability in combination with their
antimicrobial activity.19–25
The N-acylation of the amino terminal arginine (series 1) was
prepared by condensation of fatty acids to arginine methyl ester
hydrochloride using classical chemical methods.5 The application
of biotechnological procedures was not efficient for these com-
pounds.25 Series 2 was at first prepared by chemical procedures,23
however papain from Carica papaya latex was found to be a
suitable catalyst for the formation of amide (series 2) and ester
bonds (series 3) between Cbz–Arg–OMe and various long chain
alkyl amines and fatty alcohols.24 In all cases, papain deposited
onto polyamide was found to be the best biocatalyst configuration.
The preparation of arginine alkyl esters was carried out in solvent
free systems using the same alcohol reagent. Both series were
enzymatically synthesized at multigram scale with a purity higher
than 99%.
N-Alkyl amide and ester derivatives of Na-protected amino acids
have also been prepared by lipases. In a study carried out with
Candida antarctica and Rhizomucor miehei lipases, it was found
that these enzymes could readily catalyse the condensation of a
number of Na-Cbz-amino acids with a,w-alkyldiamines or fatty
alcohols.26
N-Alkyl amide and side chain-substituted lipoamino acids have
also been prepared by proteases and lipases. It was found that these
enzymes could readily catalyse the condensation of a number of
amino acids with fatty acids and triglycerides.27
2.2 Properties
Our group has reported that long chain Na-acyl arginine methyl
ester compounds (series 1 Scheme 3) are cationic surfactants with
a satisfactory toxicity profile, high biodegradability and a surface
activity comparable to that of conventional long chain quaternary
ammonium salts. We have demonstrated that the morphology of
Scheme 2 Different types of linkages between an amino acid and a hydrophobic alkyl chain: acyl bond derivatives (1), alkyl bond derivatives (2), amide
bond derivatives (3) and ester bond derivatives (4).
Scheme 3 Chemical structure of single chain arginine-based cationic
surfactants.
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their micelle aggregates and lyotropic phases depends on the
hydrophobic moiety, temperature, composition and electrolyte
content in the system. As a result, we have found that compounds
of series 1 show a rich and unusual phase behavior.28–30 For
instance, reversed vesicles (dispersion of lamellar liquid crystals in
non-polar media) with biocompatible properties occurred in the
lecithin-LAM–squalane system.31 The PAM homologue was the
only compound that showed lamellar lyotropic liquid crystals in the
binary water–surfactant system.30 These properties make them
good alternatives for a wide range of industrial applications in the
personal care, pharmaceutical and food sectors as well as in the
design and synthesis of biomaterials. Furthermore, the arginine
residue gives antimicrobial activity to the amphipathic molecule, a
valuable property for a biocompatible surfactant.32
Compared to series 1, the series 2 and 3 compounds (Scheme 3)
have two positive charged groups in the hydrophilic moiety, one in
the primary amine and a second in the guanidine function. From the
surface tension/concentration curves at 25 °C the critical micelle
concentration (CMC) which is associated with the hydrophobicity
of the molecule, the maximum surface excess concentration at the
air–aqueous solution interface (Gm) and the area per molecule
whose value indicates the minimum area per surfactant molecule at
the air–aqueous solution interface (Amin) were calculated. Table 1
summarizes the surface parameters of the three series of com-
pounds using the Gibbs adsorption equation.33 In all cases they
have the ability to decrease the surface tension of water until a
constant value is reached, gCMC, and show a clear CMC in the
surface tension–log C curves in the millimolar range. This indicates
that they can be classified as surfactants with a surface activity
similar to that of conventional cationic ones. Table 1 shows that the
CMC depends on the straight alkyl chain and the nature of the
hydrophilic moiety. For the three series of surfactants, the larger the
number of methylene groups in the alkyl chain the lower the CMC,
as would be expected from the increase in the hydrophobic
character of the molecule. The smaller the Amin, the more effective
its adsorption at the interfaces. We found that the Amin values for
series 2 and 3 (62–114 3 1022 nm2 and 96–122 3 1022 nm2,
respectively) were higher than that for series 1 with the same alkyl
chain length (67 and 62 3 10 nm2). This result indicates that the
new molecules are less packed at the interface than those of series
1. The two charged groups in series 2 and 3 tend to spread
themselves out on the interface due to an increase in the inter–
intramolecular electrostatic repulsion forces.
One important milestone in our research is the design and
development of new amino acid-based surfactants with anti-
microbial properties, which mimic natural amphiphilic cationic
peptides.21,34 To this end, Lys and Arg derivatives of long chain Na-
acyl, COO-ester and N-alkyl amide have been prepared. In
particular, the Na-acyl arginine methyl ester derivatives series 1
(Scheme 3) have turned out to be an important class of cationic
surface active compounds with a wide bactericidal activity, high
biodegradability and low toxicity profile. The antimicrobial
activities were determined in vitro on the basis of the minimum
inhibitory concentration (MIC) values, defined as the lowest
concentration of antimicrobial agent which inhibits the develop-
ment of visible growth after 24 h of incubation at 37 °C. We have
shown that essential structural factors for their antimicrobial
activity include both the length of the fatty residue (akin with their
solubility and surface activity) and the presence of the protonated
guanidine function.34,35 Amphoteric lipopeptide surfactants with
antimicrobial activity comparable to those of LAM were found
when neutral Gly or Phe amino acids were condensed to the Na-
lauroyl arginine.10 More interestingly, condensation of a Na-acyl-
arginine residue to an acid-hydrolyzed collagen gave rise to a
family of amphoteric protein-based surfactants with antimicrobial
activity, the homologue of C14 carbon atoms being the most
active.10 The activity of all these amphoteric Na-acyl arginine
surfactants could be due to the presence of the long chain Na-acyl-
arginine residue and to the absence of intramolecular ionic
interactions in the molecule. The free guanidine group together
with the surface activity of these compounds could interact with the
polyanionic components of the cell surface triggering the biocide
mechanisms of these surfactants. In accordance with Ferguson’s
principle,36 the antimicrobial activity might be related to the
combination of several physicochemical properties such as surface
activity, adsorption and solubility.
The ultimate biodegradability37 measurements for the three
series of arginine-based cationic surfactants showed that all
homologues (except AMA) can be considered biodegradable.38
Interestingly, using ester type bonds (series 3, Scheme 3) to link the
hydrophobic and hydrophilic moieties accelerates their biodegrada-
tion considerably. This fact has also been described for sugar-based
surfactants.39
The haemolytic activity, HC50, which is the concentration of
surfactant that causes 50% of haemolysis of red blood cells from
healthy human donors40 and the HC50/D ratio, where D is the
haemoglobin denaturising index, are the parameters commonly
measured for evaluating the potential toxicity of the surfactants.
The HC50/D or L/D is used for predicting the potential ocular
irritation relative to sodium dodecyl sulfate (SDS) (L/DSDS: 0.44;
irritant). The values of HC50 for series 1, 2 and 3 (Scheme 3)
demonstrated that these compounds can be considered non-
haemolysing agents (HC50 < 1000 mg mL21). For comparison’s
sake, commercial cationic surfactants have HC50 ranging from 4 to
15 mg mL21. Furthermore, according to the results of the L/D ratio
first and by the in vivo eye irritation Draize test later, these linear
arginine-based surfactants have no irritant effect on the eyes (non
eye-irritants, L/D > 100).40
2.3 Applications
The application of synthetic acyl amino acid/peptide vesicles as
drug carriers as well as for the preparation of functional liposomes
with lipopeptide ligands have been examined by several authors in
recent years.41,42 Vesicles of long aliphatic chain Na acyl amino
acids showed encapsulation efficiencies for solutes comparable to
that of conventional liposomes of lecithin. Recently, a new
technology has emerged for the transfer of foreign DNA into cells
forming non-toxic hydrophobic ion-paired complexes between
long chain arginine alkyl esters (Scheme 3 series 3) with DNA.43
Lipoamino acids are also particularly attractive as antiviral
agents. Certain acyl amino acid derivatives have been found to
produce inhibition on influenza neuraminidase.44 A number of Na-
palmitoylated amino acids/peptides have been incorporated into
model membranes affecting the transition temperature between the
Table 1 Surface active properties of single chain surfactants from arginine
at 25 °C27–29,39
Com-
pound
gcmca/
1023 N m21
CMCb/
1023 mol dm23
Gmc/
1014 mol m22
Amind/
102 nm2
CAMe 40 16
LAMe 32 5.8 67
MAMe 32 2 62
ACAf 35 26 1.79 62
ALAf 37 1.8 1.24 90
AMAf 33 0.7 0.97 114
AOEg 35 38 1.15 96
ACEg 34 13 1.54 72
ALEg 30 5 0.91 122
a Surface tension at the critical micelle concentration. b Critical micelle
concentration. c Maximum surface excess concentration at the air–aqueous
solution interface. d Minimum area per surfactant molecule at the air–
aqueous solution interface. e Compounds of series 1 (Scheme 3). f Com-
pounds of series 2 (Scheme 3). g Compounds of series 3 (Scheme 3).
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bilayer to hexagonal aggregation, a property associated with
antiviral activity against the Cantell strain of the Sendai virus
(parainfluenza type 1).45
Polymeric amino acid-based surfactants for enantiomeric separa-
tions using capillary electrokinetic chromatography (EKC) has
been reported in the bibliography.46–48 The effect of the position
and number of chiral centers, amino acid order and steric effects
have been evaluated.48
3 Amino acid-based gemini surfactants
Gemini surfactants are a novel class of amphipathic compounds
consisting of two hydrophilic and two hydrophobic groups per
molecule linked through a spacer chain. These molecules can be
considered dimers of the single chain conventional surfactants of
one hydrophilic and one hydrophobic group. Their interest lies in
the number of unexpected surface activity properties, which make
them superior to the conventional surfactants. These molecules
show extremely low CMC (CMC, a fundamental parameter of
surfactants close related to their hydrophobicity), solubilizing,
wetting, foaming, antimicrobial and lime soap dispersion proper-
ties.49–56
3.1 Synthesis
In the past 15 years, many different types of gemini surfactants have
been synthesized.57 Reviews concerning the synthesis and struc-
tures of gemini surfactants have been published.58–61
A number of surfactant structures with a variety of hydrophilic
head groups and hydrophobic tails of different chain lengths have
been reported in an effort to increase their surface-active proper-
ties.62–66 Several papers have been published addressing the
synthesis and properties of a new type of bifunctional amphiphilic
cationic compounds with an effective surfactant and antimicrobial
behaviour of the gemini type called bis quaternary ammonium
halide surfactants, or bis(Quats).67 These are double-headed
surfactants in which two alkyldimethyl quaternary ammonium
groups per molecule are linked by a hydrocarbon spacer chain.
Owing to their extraordinary activity, they are regarded as an
outstanding new generation of cationic surfactants with excellent
performance with regard to solubilization, soil cleaning, and oil
recovery. However, they are very stable molecules with a
questionable chemical and biological degradability.68
A strategy to reduce the environmental impact and potential
toxicity is to build up gemini structures from environmentally
friendly single chain arginine-based surfactants. To this end, our
group has chemically synthesized and studied a new class of gemini
cationic surfactants derived from the arginine: the Na,Nw-bis(Na-
acylarginine)a,w-alkylendiamides or bis(Args).25,69–73 These com-
pounds consist of two symmetrical long chain Na-acyl-L-arginine
residues of twelve Na,Nw-bis(Na-lauroylarginine)a,w-alkylendia-
mides [Cn(LA)2 series], and ten carbons atoms, Na,Nw-bis(Na-
caproylarginine)a,w-alkylendiamides [Cn(CA)2 series], linked by
amide bonds to an a,w-alkylenediamine spacer chain of varying
length (n = 2–10) (Scheme 4). This particular alkylenediamine
spacer chain was chosen to control the distance between the
charged sites of the molecule which modify the inter- and intra-
hydrophilic–hydrophobic interactions. The bis(Args) were investi-
gated in an attempt to develop a new class of environmentally
friendly amino acid-based surfactants with surface activity exceed-
ing that of CAM and LAM, and with at least the same antimicrobial,
toxicity and biodegradability properties.
Recently a series of bis(Args) have been prepared at multigram
scale by a chemoenzymatic approach using papain deposited onto
Celite for the best results70,74 (Scheme 4 right).
3.2 Properties
In the light of our studies, most gemini surfactant properties are
superior to the corresponding conventional monomeric surfactants.
They were found to be more efficient surface active molecules than
the single chain structures: Their CMC are at least one order of
magnitude lower than that of the corresponding monomeric
surfactants71 and they are 10–100 times more efficient at reducing
the surface tension of water and in foam stability.75
To establish the effect of the dimerization on the antimicrobial
activity as well as the influence of the alkyl and the spacer chain
length of bis(Args), the evaluation of in vivo membrane-disrupting
properties was made using cell bacteria as biological membranes.
The dilution antimicrobial susceptibility test was carried out and the
minimum inhibitory concentration (MIC) values were determined.
Bis(Args) exhibited a broad spectrum of preservation capacity at
MIC values in the range from 4 to 125 mg mL21.69 The dimerization
enhanced the antimicrobial activity for the gemini Cn(CA)2
compared with CAM. Given the peculiar structure of bis(Args), the
compounds of the Cn(CA)2 series have a hydrophobicity which is
more than twice the hydrophobicity of CAM. However, the
presence of two ionic arginine groups in one molecule of Cn(CA)2
can make a positive contribution to the degree of the hydration of
this series, showing a water-solubility similar to that of CAM.
These two characteristics in the molecule can result in a more
effective adsorption and diffusion of Cn(CA)2 on the cell interface,
resulting in an antimicrobial action at lower concentrations.
Bearing in mind that biological membranes are essentially
nonpolar interfaces, evidence exists that the toxicity of surfactants
against the aquatic species tested is caused by the ability of the
monomers to disrupt the integral membrane by a hydrophobic/ionic
adsorption phenomenon at the cell membrane–water interface in a
similar way to that of the antimicrobial mode action. Acute toxicity
tests on freshwater crustacea (Daphnia magna), a very sensitive
invertebrate,76 as well as on saltwater bacteria (Photobacterium
phosphoreum)77 were carried out to assess the aquatic toxicity.
These standard tests represent two of the trophic levels which can
be exposed to the cationic surfactants. Concentration values that
cause inmobilization in 50% of the Daphnia after 24 hours exposure
(IC50) and 50% reduction in the light emitted by the bacteria after
30 minutes exposure (EC50) were determined. Values of IC50 and
EC50 for the bis(Args) together with those of LAM and CAM are
summarised in Table 2.78 Values reported for two series of
Scheme 4 Structures of bis(Args) gemini cationic surfactants prepared by
chemical procedures (left) and chemo-enzymatic procedures (right).
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conventional mono(Quats) dodecyltriammonium bromide (DTAB)
and hexadecyltriammonium bromide (HTAB) are also indicated.
When increasing the hydrophobicity of the molecule, the acute
toxicity raised for each series of surfactants is in agreement with
their CMC values, Table 3. Thus, Cn(CA)2 were less toxic than the
Cn(LA)2 compounds due to their lower hydrophobic character.
Interestingly, IC50 values for Cn(CA)2 compounds were similar to
that of LAM. Furthermore, all of them were one order of magnitude
less toxic than the conventional mono(Quats).
Due to the complexity and hydrophobicity of the gemini
compared with the single chain structures, the biodegradation rate
of single chain structures such as LAM (90% in 14 days), was
higher than that of the bis(Args) (50–90% in 14 days). The
biodegradation rate of bis(Args) decreased when both the spacer
chain and the alkyl chain length increased. Hence, the higher the
hydrophobicity of the surfactants the lower their biodegradation
rate78.
The haemolysis test showed again that the highest HC50 values
were obtained for the compounds with the highest hydrophobic
character, namely, those with the longest alkyl and spacer chain
lengths. There is considerable difference between the HC50 of these
new gemini surfactants and those bearing a quaternary ammonium
group at the polar head. MonoQuats have HC50 values between
0.05 and 0.1 mg m21. The introduction of a hydroxyl function to the
spacer chain make the compound more hydrophilic, in consequence
the CMC increases and the HC50 increases.
Dimerization of LAM and CAM yields environmentally friendly
antimicrobial gemini surfactants with lower hemolytic activity,
aquatic toxicity and efficient surface activity than other cationic
surfactants, (i.e. monoQuats). The increase of hydrophobicity of
these molecules is a negative structural parameter for their
environmental behaviour.
3.3 Applications
Gene therapy is an important topic in life science. It depends on
effective techniques for safe introduction of the selected gene into
living cells. Recently, Gemini surfactants have been found to be
particularly promising as potential vehicles for the transport of
bioactive molecules. Lysine and 2,4-diaminobutyric acid form
polycationic gemini surfactants, by relatively simple synthesis
using standard peptide chemistry.79,80 These polycationic gemini
surfactants and spermine-based gemini surfactants are attracting
much attention as efficient agents in gene delivery.81–86
4 Amino acid glyceride conjugates
4.1 Synthesis
Amino acid glyceride conjugates (i.e. glycero amino acids)
constitute a novel class of lipoamino acids, which can be considered
analogues of mono and diacylglycerides and phospholipids (1 and
2 Scheme 5). They consist of one or two aliphatic chains and one
amino acid, as the polar head, linked together through ester bonds
in the glycerol backbone.
Our group has synthesized these products using chemical and
enzymatic methodologies.25,87–89 The first enzymochemical syn-
thetic strategy of amino acid glyceride conjugates was described by
Valivety et al.90 The synthesis started with the preparation of amino
acid glyceryl esters namely 1-O-(Na-protected-aminoacyl)glycer-
ols. The preparation of these compounds was performed using an
acid catalyst such as BF3 at elevated temperatures in glycerol,
which served as solvent and reactant. Alternatively, they can be
obtained by enzymatic methodology using hydrolases (Scheme 6).
Proteases and lipases were found to be a versatile catalyst for this
reaction.91–92 A variety of protected amino acid glyceryl ester
derivatives were obtained in 46–98% yield under mild and selective
conditions.
In a second step, the free hydroxyl groups of the glyceryl moiety
were acylated with fatty acid using lipases as catalyst. According to
Valivety et al.,60,90 both Novozyme and Lipozyme can be
successfully used as biocatalysts showing a high regioselectivity
towards the primary hydroxyl group of the amino acid glyceryl
ester derivative. Hence, by this methodology only the 1(3)-aminoa-
cyl monoglycerides are likely to be prepared.
We have developed a novel methodology to obtain both
1-monoacyl- and 1,2-diacyl-3-aminoacyl glycerol88 (see Scheme 5,
Table 2 Aquatic toxicity values of Cn(LA)2, Cn(CA)2 series and CAM,
LAM, DTAB and HTAB.77
Daphnia magna
IC50a/mg L21
Photobacterium
phosphoreum EC50b/mg L21
Compounds mean
95%
confidence
range mean
95%
confidence
range
C2(LA)2 4.4 (3.5–5.3) 28 (18–43)
C3(LA)2 2.1 (1.8–2.4) 2.4 (2.2–2.7)
C4(LA)2 4.6 (3.9–5.2) 5.8 (4.3–8.0)
C6(LA)2 2.4 (1.9–2.5) 3.0 (2.0–4.5)
C9(LA)2 2.2 (1.9–2.5) 13 (10–17)
C10(LA)2 16 (11–20) 20 (15–28)
LAM 15 (12–18) 12 (10–14)
DTAB 0.38 (0.36–0.40) 0.24 (0.20–0.30)
HTAB 0.13 (0.11–0.15) 0.63 (0.40–0.98)
C2(CA)2 16 (11–20) 1.5 (1.2–1.9)
C3(CA)2 16 (11–20) 1.1 (0.5–2.1)
C4(CA)2 12 (7–17) 0.9 (0.4–2.2)
C6(CA)2 15 (11–19) 1.3 (0.3–5.6)
C9(CA)2 5.5 (2.7–8.2) 1.1 (0.7–1.7)
C10(CA)2 7.5 (5.0–10) 2.7 (1.2–5.8)
CAM 77 (56–98) 4.0 (3.1–5.3)
a Concentration values that cause 50% inhibition in the crustacean mobility
after 24 h of exposure. b Concentration values that cause 50% reduction in
the light emitted by the bacteria after 30 min of exposure.
Table 3 CMC values (g L21) and HC50 (mg L21) of CAM, LAM and
bis(Args) homologues on human red blood cells.77
Compound CMCa/g L21 HC50b/mg L21
CAM 6.05 38.5
C3(CA)2 1.53 110.5
C6(CA)2 1.29 9.0
C9(CA)2 9.35 8.7
LAM 2.44 20.8
C3(LA)2 4.60 80.7
C3(OH)(LA)2 5.89 > 200
C3(OA)2 49.77 > 200
a Critical micelle concentration. b Hemolysis value. Scheme 5 Structures of amino acid glyceride conjugates: mono acyl
derivatives (1) and diacyl derivatives (2).
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1 and 2, respectively). Mono and diacylation of amino acid glyceryl
ester may be carried out using selective lipases by taking advantage
of the spontaneous intramolecular acyl-migration reaction that
occurs in partial glycerides.93–95 Thus, the 1(3)-acylated product
may undergo intramolecular 1(3)?2 acyl migration and the
resulting 1,2(2,3)-isomer subsequently be acylated at the free
primary hydroxyl group by the lipase. Accordingly, the yield of
diacylated product will depend on both the rate of intramolecular
acyl-migration and the enzymatic esterification of the newly free
primary hydroxyl of the monoacylated derivative. Both processes
are influenced by the reaction conditions, such as solvent, support
for enzyme immobilization, buffer salts and by the amino acid
glyceryl ester derivative. All the enzymatic acylations were carried
out in solvent free media, at a temperature around the melting point
of the corresponding fatty acid.
We have found that the 1,2-diacyl-3-aminoacyl glycerol deriva-
tives were in fact a mixture of two regioisomers: 1,2-diacyl-rac-
glycero-3-(amino acid) derivative as the major one, and 1,3-dilaur-
oyl-glycero-2-(amino acid) derivative. With this methodology a
series of mono and dilauroylated glycerol derivatives of arginine,
aspartic acid, glutamic acid, asparagine, glutamine and tyrosine
were prepared.88 All of them were mixtures of diastereoisomers and
regioisomers except the dilauroylated derivative of glutamine.
Here, both 1,3-dilauroyl-glycero-2-O-(Na-acetyl-L-glutamine) and
1,2-dilauroyl-rac-glycero-3-O-(Na-acetyl-L-glutamine) were sepa-
rarated by flash chromatography on silica.
Chemically, two biocompatible cationic surfactants from the
amino acid argininine were prepared (Scheme 5, 2, n: 10, 12).96 The
first compound is 1,2-dilauroyl-rac-glycero-3-O-(Na-acetyl-L-argi-
nine), with 12 carbon atoms in the alkyl chains (Scheme 5, 2, n: 10)
. The second one is the 1,2-dimiristoyl-rac-glycero-3-O-(Na-
acetyl-L-arginine), with 14 carbon atoms in the alkyl chains
(Scheme 5, 2, n: 12). Henceforth, we shall refer to these compounds
as 1212RAc and 1414RAc, respectively.
The synthesis of 1212RAc and 1414RAc compounds was
achieved following a two step procedure. The first step involves the
enzymatic preparation of the arginine glyceryl ester derivative as
described in Morán et al.92 This reaction consisted of the selective
protease-catalysed esterification of one of the primary hydroxyl
groups of the glycerol with the carboxylate group of the Na-
protected amino acid. The reaction yield was 80%. The second step
consists of the preparation of 1,2-diacyl-rac-glycero-3-O-(Na-
acetyl-L-arginine) by acylation of the two remaining free hydroxyls
groups of the arginine glyceryl ester derivative with the correspond-
ing long chain acid chloride.96 The progress control of the reaction
showed that the arginine glyceryl ester derivative was first
esterified with 1 mol of acyl chloride to give the corresponding
monoacyl derivatives. With a molar ratio acid chloride : arginine
glyceryl ester derivative (1 : 3), the main reaction products were
1212RAc and 1414RAc with conversions higher than 98%. The
overall yield of these reactions after purification was in the range of
about 85–70%.
New surfactants that are analogues of lecithin have been
synthesized97–101 The structure of these non-ionic amphiphilic
compounds is based on natural dibasic (lysine) or diacidic
(glutamic or aspartic acids) amino acids. As with the lecithins, these
amino acid-based compounds have two hydrophobic tails and one
hydrophilic head. However, in the latter compounds the polar head
is of the non-ionic type (one or two chains of monomethyletherpo-
lyoxyethylene glycol) whereas in the lecithins it is of the
zwitterionic type. The central pivot in the structure of lecithins, i.e.
the glycerol, is imitated by the natural trifunctional amino acids
lysine,91–101 aspartic acid99,101 and glutamic acid.99,101 The hydro-
phobic (fatty acids or fatty amines) and hydrophilic (mono-
methyletherpolyoxyethylene amine or monomethyletherpolyethy-
lene carboxylic acid) moieties were introduced into their amino or
carboxylic functions through amine bonds, in place of the ester
bonds in lecithins. The latest variation on this theme contains two
different hydrophobes; thus creating an asymmetric structure that
displays lower water solubility and higher surface activity as well
as a slightly increased toxicity.
4.2 Properties
The physicochemical and biological properties of amino acid
glyceride conjugates have not been extensively explored yet. From
preliminary observations carried out in our lab, these novel
compounds combine the advantages of both partial glycerides and
lipoamino acids.
The influence of the temperature as a function of time on the
stability properties was studied in order to ascertain whether
chemical degradation of 1212RAc and 1414RAc compounds
occurred.102 As expected, the hydrolysis rate was higher when the
temperature increases, reaching 10% in the case of the 1414RAc
and 8.9% in the case of the 1212RAc at 40 °C after 144 hours. The
hydrolysis of 1212RAc and 1414RAc compounds is related to their
structure in which three ester bonds are present. The ester bonds
hydrolyzed under acid pH conditions. Owing to the presence of a
weak acid group, the guanidine group, aqueous solutions of these
surfactants have a slightly acid pH (pH = 4). Slow hydrolysis of the
ester bonds was promoted at this pH.
The aqueous aggregation behavior, studied by conductivity,
showed a linear increase with concentration up to a break point of
0.12 mM for 1212RAc and 0.09 mM for 14141RAc. Results for
similar nonacetylated compounds suggest that the break points
from conductivity for this new family of compounds do not
correspond to a true CMC (monomer to micelle) but some other
transition (i.e. vesicle to ribbon).102
Qualitative phase behavior studies applying the flooding method
revealed the formation of anisotropic phases in all the binary
surfactant systems studied. The compound 1212RAc forms la-
mellar liquid crystals at room temperature (25 °C) and this structure
is stable and remains stable until high temperatures are reached.
The 1414RAc also forms anisotropic phases that developed in
lamellar liquid crystals at 45 °C. Dispersions of 1212RAc and
1414RAc 0.1% in water at 35 °C revealed that their lamellar
structures (Fig. 1) spontaneously form stable multilamellar vesicles
(Fig. 2) spontaneously and easily, of diverse size and number of
bilayers.
The 1212RAc and 1414RAc surfactants can simultaneously
stabilize water-in-oil (W/O) droplets and oil-in-water droplets (O/
W), forming multiple emulsions. On account of this behavior, these
surfactants constitute an interesting alternative to the diglycerides
and lecithins in formulations that need antimicrobial properties.
The phase behaviour in the dry state of pure and regioisomeric
mixtures has been studied by differential scanning calorimetry and
small-angle X-ray diffraction complemented by polarized light
microscopy.103 The study showed the influence of the bilayer
packing as a function of the temperature.
Scheme 6 Reaction pathway for the synthesis of mono and diacylglycerol
amino acid conjugates.
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We have shown that a novel family of 1,2-diacylglycerol amino
acid-based surfactants exhibits a monolayer behaviour similar to
that found in natural phospholipids, suggesting that they may be
viable substitutes for these compounds in industrial applications,
which need multifunctional compounds.104 Use of Brewster Angle
Microscopy (BAM) image analysis of the inner textures has
revealed that condensed phases of the diacyl glycerol compounds
with 14 carbon atoms in the hydrocarbon chain exhibit hexatic
order. Variations in the chain length introduce similar changes to
those commonly found in lipid monolayers. Generally, compounds
with a 1,2-substitution pattern in the glycerol backbone exhibit a
tendency to form continuous monolayers (expanded phases) at
significantly lower molecular densities than their natural phospho-
lipid counterparts.
Our investigations with a compound bearing a 1,3-substitution
pattern [1,3-dilauroyl-glycero-2-(Na-acetyl-L-glutamine)] show
that it forms rough and compact LC domains, very different from
those observed in phospholipid monolayers.104
In summary, amino acid-based surfactants constitute a class of
bio-based surfactants with excellent surface properties, wide
biological activity, low potential toxicity and low environmental
impact. Moreover, they can be prepared efficiently by chemical and
enzymatic catalysis. All these features make them an outstanding
clean and safe alternative to conventional specialty surfactants.
Hence, this new generation of surfactants will contribute to meet
the increasing demand for environmentally friendly surfactants for
pharmaceutical and food industries.
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